Results 11 to 20 of about 25,282 (212)
Aberrant expression of microRNA in polycythemia vera
Background Polycythemia vera is a clonal hematopoietic stem cell disorder in which the JAK2 V617F mutation is observed in >95% of patients, but an as yet unidentified process appears to initiate the clonal expansion of hematopoiesis.
Hana Bruchova +2 more
doaj +1 more source
Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
A variety of methods for testosterone replacement therapy (TRT) exist, and the major potential risks of TRT have been well established. The risk of developing polycythemia secondary to exogenous testosterone (T) has been reported to range from 0.4% to 40%
Katherine Lang Rotker +6 more
doaj +1 more source
Polycythemia in chronic obstructive pulmonary disease in Minia Cardiothoracic University Hospital
Background Secondary polycythemia is linked to cigarette smoking and chronic obstructive pulmonary disease (COPD). However, the prevalence of polycythemia and its possible risk factors in patients with COPD have not been widely studied.
Rasha A Abdelfattah +4 more
doaj +1 more source
Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
TET2 mutations are found in polycythemia vera and it was initially reported that there is a greater TET2 mutational burden than JAK2V617F in polycythemia vera stem cells and that TET2 mutations precede JAK2V617F.
Sabina I. Swierczek +7 more
doaj +1 more source
We analyzed the effect of hydroxyurea on the JAK2V617F allelic ratio (%JAK2V617F), measured in purified blood granulocytes, of patients with polycythemia vera and essential thrombocythemia.
François Girodon +8 more
doaj +1 more source
BackgroundParaganglioma is a rare neuroendocrine tumor and is highly associated with hereditary susceptibility genes, often occurring as part of a genetic syndrome. The genetic heterogeneity of paraganglioma poses challenges in diagnosis, counseling, and
Haiyan Yang +5 more
doaj +1 more source
Concurrent Polycythemia of Undetermined Etiology and Smouldering Plasma Cell Myeloma
The combination of polycythemia and plasma cell myeloma occurring concurrently is very rare and few cases have been reported in the literature. Further, the vast majority of these cases are cases of polycythemia vera and myeloma.
Roula Katerji, Chad A. Hudson
doaj +1 more source
Background: The coexistence of beta-thalassemia trait (BTT) and polycythemia complicates diagnosis by lowering hemoglobin (Hb) below WHO thresholds for polycythemia vera (PV), potentially masking both disorders.
Abdurrehman +5 more
doaj +1 more source

